"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about VENLAFAXINE
• Ask Community about VENLAFAXINE
• Read More Here
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

VENLAFAXINE Safety Questions, VENLAFAXINE Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about VENLAFAXINE. Our extensive database of VENLAFAXINE adverse events and VENLAFAXINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about VENLAFAXINE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

VENLAFAXINE Safety Reports

Total VENLAFAXINE reports: 181.
VENLAFAXINE FDA safety alerts: 2003 2004 2005 2006 .
Reported deaths: 11    Reported hospitalizations: 103.
Take VENLAFAXINE Side Effects Survey or Share Your VENLAFAXINE Story. Read More Here.

Showing 1-75 of 181 Next >

Health Professional from GERMANY reported VENLAFAXINE problem on May 14, 2007. Male patient, weighting 5.47 lb, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: congenital genital malformation. VENLAFAXINE dosage: unknown. Patient recovered.

VENLAFAXINE problem was reported by a Physician from GERMANY on May 29, 2007. Female patient, weighting 196.2 lb, was diagnosed with depression, anxiety and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: paraesthesia, suicidal ideation. VENLAFAXINE dosage: unknown. Patient recovered.

Physician from GERMANY reported VENLAFAXINE problem on May 21, 2007. Female patient, weighting 165.3 lb, was diagnosed with depression, dysthymic disorder and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: blood amylase increased, blood cholesterol increased, hot flush, hyperhidrosis, lipase increased, pancreatitis. VENLAFAXINE dosage: unknown. Patient recovered.

VENLAFAXINE problem was reported by a Health Professional from GERMANY on May 23, 2007. Female patient was diagnosed with anxiety, depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, intentional overdose, suicide attempt. VENLAFAXINE dosage: 300 MG DAILY. Patient recovered.

Physician from GERMANY reported VENLAFAXINE problem on June 01, 2007. Female patient, weighting 26.46 lb, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: accidental overdose. VENLAFAXINE dosage: 1 TABLET (75 MG). Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on May 30, 2007. Female patient was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: anxiety, fatigue, hyperhidrosis, mouth haemorrhage, muscle spasms, muscle twitching, nervousness, nightmare, panic reaction. VENLAFAXINE dosage: 75 MG DAILY. During the same period patient was treated with SALMETIN ROTADISK, SALBUTAMOL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported VENLAFAXINE problem on June 11, 2007. Male patient, 59 years of age, weighting 154.0 lb, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, ammonia abnormal, blood creatinine increased, blood culture positive, blood glucose increased, blood magnesium increased, blood potassium decreased, blood pressure systolic increased, blood urea increased. VENLAFAXINE dosage: 75MG DAILY PO. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Health Professional from GERMANY on June 12, 2007. Female patient was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: rectal cancer metastatic. VENLAFAXINE dosage: 150 MG DAILY. Patient recovered.

Physician from GERMANY reported VENLAFAXINE problem on June 13, 2007. Female patient, weighting 5.29 lb, was diagnosed with depression, apathy and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: umbilical cord around neck. VENLAFAXINE dosage: unknown. During the same period patient was treated with FOLIC ACID. Patient recovered.

VENLAFAXINE problem was reported by a Health Professional from GERMANY on June 25, 2007. Female patient, 39 years of age, weighting 165.3 lb, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: coma, intentional overdose, respiratory failure. VENLAFAXINE dosage: unknown. During the same period patient was treated with COCAINE, METHADONE, APONAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported VENLAFAXINE problem on June 26, 2007. Male patient, 53 years of age, weighting 160.0 lb, was diagnosed with anxiety, depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anaemia, anxiety, asthenia, asthma, dysphagia, dyspnoea, exercise tolerance decreased, fatigue. VENLAFAXINE dosage: 300MG ONCE DAILY PO. During the same period patient was treated with AMITRIPTYLINE, HYDROCODONE, GABAPENTIN, IBUPROFEN, CYCLOBENZAPRINE. Patient recovered.

VENLAFAXINE problem was reported by a Physician from GERMANY on June 22, 2007. Male patient, 38 years of age, weighting 175.7 lb, was diagnosed with personality disorder and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: restless legs syndrome. VENLAFAXINE dosage: 75 MG PER DAY. During the same period patient was treated with MELPERONE, DIAZEPAM. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported VENLAFAXINE problem on June 27, 2007. Male patient, 87 years of age, was diagnosed with depression, neuropathy and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: rash. VENLAFAXINE dosage: 75MG EVERY DAY PO. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 23, 2006. Female patient, 45 years of age, weighting 231.0 lb, was diagnosed with depression, schizophrenia and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: hepatocellular damage, liver function test abnormal. VENLAFAXINE dosage: 75 MG/DAY. During the same period patient was treated with CLOZARIL. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on June 19, 2006. Female patient, 26 years of age, was diagnosed with anxiety, depression, psychotic disorder and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, hallucination. VENLAFAXINE dosage: 37.5 MG PER DAY. During the same period patient was treated with SOLIAN, TRUXAL, TEGRETOL. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on June 28, 2006. Female patient, 75 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: vith nerve paralysis. VENLAFAXINE dosage: unknown. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on June 27, 2006. Male patient, 14 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, somnolence. VENLAFAXINE dosage: unknown. During the same period patient was treated with METHADONE, MIRTAZAPINE, OPIOIDS, TAXILAN, ZOPICLONE. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on June 26, 2006. Male patient, 45 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: anxiety, hallucination, visual, headache, ill-defined disorder, malaise, sinus tachycardia, vertigo. VENLAFAXINE dosage: 75 MG, ORAL. During the same period patient was treated with PROMETHAZINE, MIRTAZAPINE, ZOLOFT, SOLIAN. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on June 26, 2006. Male patient, 50 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, delirium, delusion, sleep disorder. VENLAFAXINE dosage: unknown. During the same period patient was treated with LORAZEPAM, MELPERONE. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on June 26, 2006. Female patient, 67 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: confusional state, delirium, disorientation, disturbance in attention, memory impairment, restlessness, sleep disorder, speech disorder. VENLAFAXINE dosage: unknown. During the same period patient was treated with AKINETON, ARICEPT, CIPRALEX, HYPNOREX. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported VENLAFAXINE problem on June 29, 2006. Female patient, 45 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: coma, hypotension, respiratory failure, suicide attempt. VENLAFAXINE dosage: 50 CAPSULES (OVERDOSE AMOUNT 3750 MG). During the same period patient was treated with DOXEPIN, KLOSTERFRAU MELISSENGEIST, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on June 26, 2006. Male patient, 45 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: anxiety, hallucination, visual, headache, heart rate increased, malaise, sinus tachycardia, vertigo. VENLAFAXINE dosage: 75 MG ORAL. During the same period patient was treated with PROMETHAZINE, MIRTAZAPINE, ZOLOFT, SOLIAN. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on July 04, 2006. Male patient, 75 years of age, was diagnosed with anxiety, depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: vith nerve paralysis. VENLAFAXINE dosage: 75 MG 1X PER 1 DAY ORAL. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on June 29, 2006. Male patient, 21 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: bradypnoea, miosis, sopor, tachycardia. VENLAFAXINE dosage: unknown. During the same period patient was treated with HEROIN, ROHYPNOL. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported VENLAFAXINE problem on July 11, 2006. Male patient, 14 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, overdose, somnolence. VENLAFAXINE dosage: unknown. During the same period patient was treated with METHADONE, MIRTAZAPINE, OPIOIDS, TAXILAN, ZOPICLONE. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Health Professional from GERMANY on July 13, 2006. Male patient, 14 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, intentional overdose, somnolence, suicide attempt. VENLAFAXINE dosage: unknown. During the same period patient was treated with METHADONE, MIRTAZAPINE, OPIOIDS, TAXILAN, ZOPICLONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on July 12, 2006. Male patient was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: accidental overdose. VENLAFAXINE dosage: 1 CAPSULE (OVERDOSE AMOUNT 75 MG). Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, weighting 222.4 lb, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: agitation, dyskinesia, hypertension, mental status changes, paranoia, pyrexia, serotonin syndrome, tachycardia, tachypnoea. VENLAFAXINE dosage: 150MG CAPSULE Q8HOURS PO. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on July 17, 2006. Female patient was diagnosed with anxiety, depression, panic attack and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: idiopathic thrombocytopenic purpura, neonatal disorder. VENLAFAXINE dosage: 75 MG 2X PER 1 DAY. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on July 18, 2006. Male patient was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, obesity, spinal disorder. VENLAFAXINE dosage: 150 MG 1X PER 1 DAY ORAL; 150 MG 1X PER 1 DAY; 225 MG, PER DAY ORAL. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on July 17, 2006. Female patient was diagnosed with anxiety, depression, panic attack and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: idiopathic thrombocytopenic purpura, thrombocytopenia neonatal. VENLAFAXINE dosage: 75 MG 2X PER 1 DAY. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Physician from GERMANY on Aug 01, 2006. Female patient, 27 years of age, was diagnosed with post-traumatic stress disorder and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: premature baby, urinary tract infection. VENLAFAXINE dosage: 225 MG PER DAY. During the same period patient was treated with AMOXICILLIN. Patient died.

Health Professional from GERMANY reported VENLAFAXINE problem on July 31, 2006. Female patient, 70 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: aspiration, atrioventricular block first degree, bradycardia, coma, intentional overdose. VENLAFAXINE dosage: 100 CAPSULES (OVERDOSE MAOUNT 7500MG) ORAL. During the same period patient was treated with MELPERONE, MEMANTINE, REMERON. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on July 31, 2006. Male patient, 59 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, sexual dysfunction, ventricular arrhythmia. VENLAFAXINE dosage: 75 MG 1X PER 1 DAY, ORAL. During the same period patient was treated with MIRTAZAPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Aug 01, 2006. Male patient was diagnosed with post-traumatic stress disorder and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: immature respiratory system, iron deficiency anaemia, neonatal disorder, premature baby. VENLAFAXINE dosage: 225 MG PER DAY ORAL. During the same period patient was treated with AMOXICILLIN. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Aug 04, 2006. Male patient, 62 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. VENLAFAXINE dosage: 75 MG ORAL. Patient died.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Aug 07, 2006. Female patient, 43 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: depression, nausea, somnolence, stomach discomfort, suicide attempt. VENLAFAXINE dosage: 10 CAPSULES (OVERDOSE AMOUNT 750MG) ORAL. During the same period patient was treated with EDRONAX, IBUPROFEN, LORAZEPAM. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Aug 17, 2006. Female patient, 71 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: aspiration, atrioventricular block first degree, blood creatine phosphokinase increased, bradycardia, coma, suicide attempt, vomiting. VENLAFAXINE dosage: 100 CAPSULES (OVERDOSE MAOUNT 7500MG, ORAL. During the same period patient was treated with MELPERONE, MEMANTINE, REMERON. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SLOVAKIA (Slovak Republic) reported VENLAFAXINE problem on Aug 22, 2006. Female patient, 35 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: intentional overdose, nausea, suicide attempt. VENLAFAXINE dosage: TEN 75 MG CAPSULES (OVERDOSE AMOUNT 750 MG). During the same period patient was treated with ALCOHOL. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from AUSTRIA on Aug 21, 2006. Female patient, 75 years of age, was diagnosed with depressive symptom and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: blood chloride decreased, blood osmolarity decreased, hyponatraemia, psychotic disorder. VENLAFAXINE dosage: unknown. During the same period patient was treated with ASPIRIN, HYDROCHLOROTHIAZIDE, LISINOPRIL, AMLODIPINE, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Sept 05, 2006. Female patient, 85 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: delirium, hallucination, paranoia. VENLAFAXINE dosage: 150 MG DAILY, ORAL. During the same period patient was treated with OXAZEPAM. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Sept 11, 2006. Female patient, 42 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, alcohol poisoning, intentional overdose, mydriasis, suicide attempt. VENLAFAXINE dosage: 30 CAPSULES (OVERDOSE AMOUNT 2250 MG). During the same period patient was treated with ALCOHOL, VALPROIC ACID. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported VENLAFAXINE problem on Sept 01, 2006. Female patient, 27 years of age, was diagnosed with tonsillitis, nasopharyngitis and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: acute tonsillitis, pharyngolaryngeal pain. VENLAFAXINE dosage: unknown. During the same period patient was treated with BROACT, ACETAMINOPHEN, CODEINE PHOSPHATE, CLINDAMYCIN HYDROCHLORIDE, MEIACT, MUCOSOLVAN. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Physician from CANADA on Sept 07, 2006. Female patient, 19 years of age, was diagnosed with postpartum depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: bipolar ii disorder, brief psychotic disorder, with postpartum onset, insomnia, intentional overdose. VENLAFAXINE dosage: 150 MG, QD. During the same period patient was treated with ACETAMINOPHEN, ZOPICLONE, QUETIAPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Sept 07, 2006. Female patient, 37 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: caesarean section, haemorrhage, placenta praevia, premature baby, premature separation of placenta. VENLAFAXINE dosage: 300 MG PER DAY. During the same period patient was treated with ENOXAPARIN. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from SPAIN on Sept 13, 2006. Female patient, 65 years of age, was diagnosed with major depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: hyperthermia, neuroleptic malignant syndrome. VENLAFAXINE dosage: 150 MG 1X PER 1 DAY, ORAL. During the same period patient was treated with ANAFRANIL, SEROQUEL. Patient was hospitalized. Patient died.

Consumer or non-health professional from AUSTRIA reported VENLAFAXINE problem on Sept 27, 2006. Male patient, 61 years of age, was diagnosed with bipolar disorder and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, vomiting. VENLAFAXINE dosage: 50 MG 1X PER 1 DAY ORAL. During the same period patient was treated with AMLODIPINE, TRAZODONE. Patient died.

VENLAFAXINE problem was reported by a Health Professional from JAPAN on Sept 26, 2006. Female patient, 58 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: dizziness, gastrointestinal inflammation, large intestine carcinoma, metastasis, nausea, vomiting. VENLAFAXINE dosage: 75 MG 1X PER 1 DAY. During the same period patient was treated with LENDORM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Sept 22, 2006. Male patient was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: hypertonia, nervousness, tremor. VENLAFAXINE dosage: 75MG PER DAY ORAL. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Sept 22, 2006. Male patient was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: hypertonia neonatal, nervousness. VENLAFAXINE dosage: 75 MG PER DAY; TRANSPLACENTAL. Patient recovered.

Health Professional from UNITED STATES reported VENLAFAXINE problem on Oct 17, 2006. Female patient, 86 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: asthenia, gait disturbance, lethargy. VENLAFAXINE dosage: 225 MG QD PO. During the same period patient was treated with ADVAIR DISKUS, ARICEPT, ASPIRIN, GLUCOTROL, LASIX, IMDUR, METFORMIN, NAPROSYN. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Physician from UNITED STATES on Oct 31, 2006. Male patient, 42 years of age, weighting 180.0 lb, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: constipation. VENLAFAXINE dosage: 150 - 300 MG DAILY PO. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Oct 27, 2006. Female patient, 68 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: coma, dehydration, hyponatraemia. VENLAFAXINE dosage: 75 MG. During the same period patient was treated with BUPRENORPHINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Oct 25, 2006. Female patient was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: coma, dehydration, hyponatraemia. VENLAFAXINE dosage: 75 MG. During the same period patient was treated with BUPRENORPHINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported VENLAFAXINE problem on Oct 21, 2006. Male patient, 27 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: cyst, pneumothorax. VENLAFAXINE dosage: unknown. During the same period patient was treated with LENDORM. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2006. Female patient, child 11 years of age, weighting 80.00 lb, was diagnosed with anxiety and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, fatigue, pyrexia, screaming, social avoidant behaviour, suicidal ideation. VENLAFAXINE dosage: 37 MG ONCE DAILY PO. During the same period patient was treated with EFFEXOR. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Oct 27, 2006. Female patient, 68 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: coma, dehydration, hyponatraemia. VENLAFAXINE dosage: unknown. During the same period patient was treated with TRANSTEC. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Oct 30, 2006. Female patient, 68 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: coma, dehydration, hyponatraemia. VENLAFAXINE dosage: 75 MG; FOR A LONGER TIME. During the same period patient was treated with BUPRENORPHINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Nov 08, 2006. Female patient was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema. VENLAFAXINE dosage: unknown. During the same period patient was treated with OPIPRAMOL. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Nov 06, 2006. Female patient, 73 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: asthenia, fatigue, hypokalaemia, hyponatraemia. VENLAFAXINE dosage: 75 MG 1X PER 1 DAY ORAL. During the same period patient was treated with METOPROLOL TARTRATE, RAMIPRIL, DELIX PLUS, DISALUNIL, NEXIUM, TOREM, GLUCOBAY. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Nov 06, 2006. Female patient, 92 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: dizziness, hypotonia, supraventricular extrasystoles. VENLAFAXINE dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, PANTOPRAZOLE, SEROQUEL, DIGITOXIN, CYNT, PREDNISOLONE. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Nov 06, 2006. Female patient, 68 years of age, was diagnosed with apathy, asthenia, pain and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: apathy, blood alkaline phosphatase increased, blood cholesterol increased, blood creatine phosphokinase increased, blood glucose decreased, blood potassium increased, blood thyroid stimulating hormone increased, blood urea increased, coma. VENLAFAXINE dosage: 75 MG PER DAY. During the same period patient was treated with VENLAFAXINE EXTENDED, VENLAFAXINE EXTENDED, BUPRENORPHINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Nov 06, 2006. Female patient, 47 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, blood pressure orthostatic abnormal, dizziness, fall, hyperventilation, sinus tachycardia, syncope. VENLAFAXINE dosage: unknown. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Nov 15, 2006. Male patient, 41 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, musculoskeletal discomfort. VENLAFAXINE dosage: 225 MG PER DAY ORAL. During the same period patient was treated with MIRTAZAPINE. Patient recovered.

Consumer or non-health professional from AUSTRIA reported VENLAFAXINE problem on Nov 14, 2006. Male patient, 26 years of age, was diagnosed with borderline personality disorder, depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: aggression, nightmare, suicidal ideation. VENLAFAXINE dosage: TWICE 150 MG ORAL. During the same period patient was treated with VENLAFAXINE EXTENDED, ANTIPSYCHOTICS. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Nov 15, 2006. Male patient, 75 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, gamma-glutamyltransferase increased, hepatic enzyme increased, lipase increased. VENLAFAXINE dosage: unknown. During the same period patient was treated with MIRTAZAPINE, RISPERDAL, ASPIRIN. Patient recovered.

Consumer or non-health professional from AUSTRIA reported VENLAFAXINE problem on Nov 17, 2006. Male patient, 26 years of age, was diagnosed with borderline personality disorder, depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: aggression, nightmare, suicidal ideation. VENLAFAXINE dosage: TWICE 150 MG. During the same period patient was treated with VENLAFAXINE EXTENDED. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from AUSTRALIA on Nov 17, 2006. Male patient, 26 years of age, was diagnosed with borderline personality disorder, depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: aggression, nightmare, suicidal ideation. VENLAFAXINE dosage: TWICE 150 MG; ORAL. During the same period patient was treated with VENLAFAXINE HYDROCHLORIDE. Patient recovered.

Health Professional from UNITED STATES reported VENLAFAXINE problem on Dec 06, 2006. Male patient, 59 years of age, weighting 243.0 lb, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: headache, hypertension. VENLAFAXINE dosage: 150 MG PO BID. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Nov 06, 2006. Female patient, 92 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: dizziness, fall, hypotension, sinus tachycardia, supraventricular extrasystoles. VENLAFAXINE dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, SEROQUEL, DIGITOXIN, CYNT, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Nov 28, 2006. Female patient, 48 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: bowel sounds abnormal, fatigue, intentional overdose, suicide attempt. VENLAFAXINE dosage: 40 CAPSULES (OVERDOSE AMOUNT 3000 MG). Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from GERMANY on Nov 24, 2006. Female patient, 18 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: disorientation, dysarthria, intentional overdose, suicide attempt, tachycardia. VENLAFAXINE dosage: unknown. During the same period patient was treated with ABILIFY, VIVINOX SCHLAFDRAGEES. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Nov 27, 2006. Male patient, 70 years of age, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal hypomotility, hypotension, intentional overdose, somnolence, suicide attempt, tachycardia. VENLAFAXINE dosage: 50 CAPSULES (OVERDOSE AMOUNT 3750 MG) ORAL. During the same period patient was treated with SEROQUEL. Patient was hospitalized. Patient recovered.

VENLAFAXINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2006. Female patient, 50 years of age, weighting 138.0 lb, was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, pancreatitis. VENLAFAXINE dosage: unknown. During the same period patient was treated with ATENOLOL, ZYPREXA. Patient was hospitalized. Patient died on 10/23/2003.

Consumer or non-health professional from GERMANY reported VENLAFAXINE problem on Dec 08, 2006. Female patient, 58 years of age, was diagnosed with depression and was treated with VENLAFAXINE. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis, hepatic steatosis. VENLAFAXINE dosage: 75 MG 1X PER 1 DAY ORAL. Patient recovered.

Showing 1-75 of 181 Next >

Ask Our Patient Community about VENLAFAXINE
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate